Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan J Garber

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Diabetes, Obesity & Metabolism|August 19, 2007
Premixed insulin treatment for type 2 diabetes: analogue or human?Alan J Garber, Robert Ligthelm, Jens S Christiansen, et al.
Journal of the American Geriatrics Society|November 6, 2007
Lower risk of hypoglycemia with insulin detemir than with neutral protamine hagedorn insulin in older persons with type 2 diabetes: a pooled analysis of phase III trialsAlan J Garber, Per Clauson, Claus B Pedersen, et al.
The American Journal of Medicine|October 27, 2012
Building a solid foundation in diabetes: the nuts and bolts of insulin therapyAlan J Garber, Thomas Repas, Davida F Kruger, et al.
Preventive Cardiology|October 6, 2007
Reducing the risk of stroke through appropriate targets and treatmentsMichael H Davidson, Jan Basile, Alan J Garber, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 15, 2013
Current issues in GLP-1 receptor agonist therapy for type 2 diabetesZachary T Bloomgarden, Lawrence Blonde, Alan J Garber, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 11, 2012
American Association of Clinical Endocrinologists' position statement on obesity and obesity medicineJeffrey I Mechanick, Alan J Garber, Yehuda Handelsman, et al.
Diabetes Care|February 6, 2007
Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metforminEmanuele Bosi, Riccardo Paolo Camisasca, Carole Collober, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 15, 2019
DYSGLYCEMIA-BASED CHRONIC DISEASE: AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS POSITION STATEMENTJeffrey I Mechanick, Alan J Garber, George Grunberger, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 23, 2013
The role of bromocriptine-QR in the management of type 2 diabetes expert panel recommendationsAlan J Garber, Lawrence Blonde, Zachary T Bloomgarden, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetesAlan J Garber, Daniel S Donovan, Paresh Dandona, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Diabetes, Obesity & Metabolism|August 19, 2007
Premixed insulin treatment for type 2 diabetes: analogue or human?Alan J Garber, Robert Ligthelm, Jens S Christiansen, et al.
Journal of the American Geriatrics Society|November 6, 2007
Lower risk of hypoglycemia with insulin detemir than with neutral protamine hagedorn insulin in older persons with type 2 diabetes: a pooled analysis of phase III trialsAlan J Garber, Per Clauson, Claus B Pedersen, et al.
The American Journal of Medicine|October 27, 2012
Building a solid foundation in diabetes: the nuts and bolts of insulin therapyAlan J Garber, Thomas Repas, Davida F Kruger, et al.
Preventive Cardiology|October 6, 2007
Reducing the risk of stroke through appropriate targets and treatmentsMichael H Davidson, Jan Basile, Alan J Garber, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 15, 2013
Current issues in GLP-1 receptor agonist therapy for type 2 diabetesZachary T Bloomgarden, Lawrence Blonde, Alan J Garber, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 11, 2012
American Association of Clinical Endocrinologists' position statement on obesity and obesity medicineJeffrey I Mechanick, Alan J Garber, Yehuda Handelsman, et al.
Diabetes Care|February 6, 2007
Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metforminEmanuele Bosi, Riccardo Paolo Camisasca, Carole Collober, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 15, 2019
DYSGLYCEMIA-BASED CHRONIC DISEASE: AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS POSITION STATEMENTJeffrey I Mechanick, Alan J Garber, George Grunberger, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 23, 2013
The role of bromocriptine-QR in the management of type 2 diabetes expert panel recommendationsAlan J Garber, Lawrence Blonde, Zachary T Bloomgarden, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2003
Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetesAlan J Garber, Daniel S Donovan, Paresh Dandona, et al.
Pageof 10